首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Postprocedural PAI-1 activity is a risk marker of subsequent clinical restenosis in patients both with and without stent implantation after elective balloon PTCA.
【24h】

Postprocedural PAI-1 activity is a risk marker of subsequent clinical restenosis in patients both with and without stent implantation after elective balloon PTCA.

机译:选择性气囊PTCA植入后和未植入支架的患者,术后PAI-1活性是随后发生临床再狭窄的危险标志。

获取原文
获取原文并翻译 | 示例
           

摘要

Stent implantation after balloon dilation of coronary arteries has improved clinical prognosis in patients undergoing transluminal coronary angioplasty (PTCA), but late restenosis remains a relevant problem. A previous study has indicated that PAI-1 activity changes immediately after PTCA without stent implantation are predictive of clinical restenosis. The present study was aimed to investigate the early PAI-1 changes and fibrin formation in patients undergoing elective PTCA with stent implantation. PAI-1 activity and D-dimer plasma levels were evaluated in two groups of patients (G1 underwent only elective balloon PTCA and G2 underwent elective PTCA with stent implantation) before and after the procedure. At the end of the procedure, PAI-1 activity significantly decreased, while D-dimer levels significantly increased in both groups. Post-PTCA D-dimer levels in the group with stent implantation were significantly higher than in the other group (P<.05). In both groups of patients, the post-PTCA PAI-1 activity was higher in patients with subsequent clinical recurrence with restenosis (P<.005 in G1 and P<.0005 in G2) than in those without, whereas no differences were found in D-dimer levels. In conclusion, our results demonstrate that fibrin formation assessed by D-dimer levels is enhanced by stent implantation. However, this behaviour is not related, differently from PAI-1 changes, to subsequent occurrence of clinical restenosis.
机译:冠状动脉球囊扩张术后支架植入术改善了患者的临床预后,但晚期再狭窄仍是一个相关问题。先前的研究表明,不进行支架植入的PTCA术后PAI-1活性立即改变可预示临床再狭窄。本研究旨在调查接受选择性支架植入的PTCA患者的早期PAI-1变化和纤维蛋白形成。在手术前后,评估两组患者的PAI-1活性和D-二聚体血浆水平(G1仅接受择期球囊PTCA,G2接受经择期PTCA。在该过程结束时,两组的PAI-1活性均显着降低,而D-二聚体水平显着升高。支架植入组的PTCA术后D-二聚体水平显着高于其他组(P <.05)。在两组患者中,具有再狭窄的随后临床复发患者(G1中P <.005,G2中P <.0005)的患者中,PTCA PAI-1的活性均高于未患有再狭窄的患者。 D-二聚体水平。总之,我们的结果表明,通过D-二聚体水平评估的纤维蛋白形成可以通过支架植入得到增强。但是,这种行为与PAI-1的变化不同,与随后发生的临床再狭窄无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号